Potential Drug-Drug Interaction Assessments: In Vitro Studies, Data Interpretation and Modeling, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will assess the potential of DDIs by in vitro studies and discuss application of the FDA guidance to DDI study design, data interpretation and modelling. Attendees will get an understanding of fundamental theories and development strategies of PBPK models.

Xtalks Life Science Webinars

We will also share our interpretations, as regulatory agencies recommend different approaches for calculation of the DDI potentials including static and PBPK models.

The FDA recently approved updated regulatory guidance for drug-drug interactions (DDIs). This webinar will focus on how to follow the FDA guidance, design in vitro studies, interpret the data and assess potential drug-drug interactions, using both static and Physiologically Based Pharmacokinetic (PBPK) models.

We will also share our interpretations, as regulatory agencies recommend different approaches for calculation of the DDI potentials including static and PBPK models.

Co-administration of multiple drugs may potentially cause a drug-drug interaction (DDI) in which one drug alters the exposure of another, resulting in either therapeutic failure or risk of a patient’s life. In vitro studies are key to assessing potential DDIs because they are cost-effective, time-saving and can help to understand the mechanisms of DDI and provide directives to clinical trials (clinical trials should not be used to screen potential DDIs because of high costs, lengthy duration and ethical considerations, but they should be used to confirm potential DDIs recommended from in vitro studies and corresponding modeling).

Join Gang Luo, Associate Scientific Director, Covance and Mingguang Li, Associate Scientific Director, Covance in a live webinar on on static & PBPK modelling to assess potential DDIs on Tuesday, June 16, 2020 at 12pm EDT (5pm BST/UK).

For more information or to register for this event, visit Potential Drug-Drug Interaction Assessments: In Vitro Studies, Data Interpretation and Modeling.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website